All Stories

  1. The importance of challenging dogma with patient data
  2. A Unique Patient Stratification Method Combined with a Machine Learning Approach Identifies Novel Genetic Susceptibility and Protective Factors for Severe COVID-19 in a Hungarian Population
  3. Population- and haplotype-dependent variation around TYR rs1126809: an in silico study suggesting new directions for melanoma risk research
  4. A Novel Germline Frameshift Variant in the Tumor Suppressor Gene OBSCN in a Melanoma Patient
  5. Truncating CYLD Pathogenic Variants in CYLD Cutaneous Syndrome Distinctly Influence CYLD Proteostasis and NF-κB Signaling
  6. Frequent cutaneous manifestations of rare monogenic dental diseases: a review of OMIM data and cases from own clinical practice
  7. Timely recognition of a probably life-threatening genodermatosis: familial case report of hereditary leiomyomatosis and renal cell cancer
  8. Novel Pathogenic Variant of the TRRAP Gene Detected in a Hungarian Family with Autosomal Dominant Non-Syndromic Hearing Loss
  9. Novel Pathogenic Variant of the TRRAP Gene Detected in a Hungarian Family with Autosomal Dominant Non-Syndromic Hearing Loss
  10. Novel FANCI and RAD54B Variants and the Observed Clinical Outcomes in a Hungarian Melanoma Cohort
  11. Novel Variants in Medium and Low Penetrance Predisposing Genes in a Hungarian Malignant Melanoma Cohort With Increased Risk
  12. Missing Heritability in Albinism: Deep Characterization of a Hungarian Albinism Cohort Raises the Possibility of the Digenic Genetic Background of the Disease
  13. A novel de novo truncating variant in a Hungarian patient with CTNNB1 neurodevelopmental disorder
  14. Whole-Exome Sequencing Identified Two Novel Pathogenic Mutations in the PTCH1 Gene in BCNS
  15. Genetic Etiology of Nonsyndromic Hearing Loss in Hungarian Patients
  16. Homozygous ITGA3 Missense Mutation in Adults in a Family with Syndromic Epidermolysis Bullosa (ILNEB) without Pulmonary Involvement
  17. Genetic Testing in CYLD Cutaneous Syndrome: An Update
  18. Report of a Novel ALOX12B Mutation in Self-Improving Collodion Ichthyosis with an Overview of the Genetic Background of the Collodion Baby Phenotype
  19. TRAF3 and NBR1 both influence the effect of the disease‐causing CYLD(Arg936X) mutation on NF‐κB activity
  20. Identification of putative phenotype‐modifying genetic factors associated with phenotypic diversity in Brooke‐Spiegler syndrome
  21. Identification of putative genetic modifying factors that influence the development of Papillon–Lefévre or Haim–Munk syndrome phenotypes
  22. Identification of putative phenotype-modifying genetic factors associated with phenotypic diversity in Brooke-Spiegler syndrome
  23. A novel nonsense mutation of the CYLD gene in a Turkish family with multiple familial trichoepithelioma
  24. A comparative analysis of national Olympic swimming team members’ and para-swimming team members’ psychological profiles
  25. Brooke–Spiegler Syndrome: Two Patients From a Turkish Family With Multiple Familial Trichoepithelioma
  26. 304 Identification of putative genetic modifying factors influencing the development of Papillon-Lefévre or Haim-Munk syndrome phenotypes
  27. 305 Putative phenotype modifying genetic factors associated with phenotypic diversity in Brooke-Spiegler syndrome
  28. The management and genetic background of pityriasis rubra pilaris: a single‐centre experience
  29. A novel WDR62 missense mutation in microcephaly with abnormal cortical architecture and review of the literature
  30. Genetic investigation confirmed the clinical phenotype of congenital chloride diarrhea in a Hungarian patient: a case report
  31. Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis
  32. Nuclear Factor κB Activation in a Type V Pityriasis Rubra Pilaris Patient Harboring Multiple CARD14 Variants
  33. Phenotypic diversity of the recurrent p.Val379Leu missense mutation of the TGM1 gene
  34. 472 CARD14 variants in pityriasis rubra pilaris
  35. The rs13388259 Intergenic Polymorphism in the Genomic Context of theBCYRN1Gene Is Associated with Parkinson’s Disease in the Hungarian Population
  36. 233 Identification of genetic modifying factors responsible for the development of the distinct Papillon-Lefévre syndrome and Haim-Munk syndrome clinical phenotypes
  37. 318 The functional characterization of CARD14 variants in pityriasis rubra pilaris affected skin and keratinocytes
  38. A nagyobb méretű géndeletiók jelentősége a sclerosis tuberosa diagnosztikájában: az első magyar esetek bemutatása
  39. Delineating the genetic heterogeneity of OCA in Hungarian patients
  40. Atypical neurofibromatosis type 1 with unilateral limb hypertrophy mimicking overgrowth syndrome
  41. Genetic analysis of the SOD1 and C9ORF72 genes in Hungarian patients with amyotrophic lateral sclerosis
  42. High-throughput sequencing revealed a novel SETX mutation in a Hungarian patient with amyotrophic lateral sclerosis
  43. Identification of two novel mutations in the SLC45A2 gene in a Hungarian pedigree affected by unusual OCA type 4
  44. Electrochemotherapy for Non-melanoma Skin Cancer in a Child with Xeroderma Pigmentosum
  45. Epidermolyticus ichthyosis
  46. Pharmacological Targeting of the Epidermal Barrier
  47. 168 Genetic investigations in the CYLD mutation-caused disease spectrum
  48. Cell-Free DNA Analysis of Targeted Genomic Regions in Maternal Plasma for Non-Invasive Prenatal Testing of Trisomy 21, Trisomy 18, Trisomy 13, and Fetal Sex
  49. Somatic mosaicism of the PIK3CA gene identified in a Hungarian girl with macrodactyly and syndactyly
  50. The CYLD p.R758X worldwide recurrent nonsense mutation detected in patients with multiple familial trichoepithelioma type 1, Brooke-Spiegler syndrome and familial cylindromatosis represents a mutational hotspot in the gene
  51. Analysis of urinary cathepsin C for diagnosing Papillon–Lefèvre syndrome
  52. Phenotypical diversity of patients with LEOPARD syndrome carrying the worldwide recurrent p.Tyr279Cys PTPN11 mutation
  53. The clinical manifestations of two novel SPAST mutations
  54. One mutation, two phenotypes: a single nonsense mutation of theCTSCgene causes two clinically distinct phenotypes
  55. A jéghegy csúcsa: multiplex faggyúmirigy-eredetű bőrtumor coloncarcinomában. Muir–Torre-szindróma
  56. CYLD and Brooke-Spiegler syndrome, familial cylindromatosis and thrichoeptheliomatosis
  57. Multiple familial trichoepithelioma: Report of a Spanish family associated with a mutation in the CYLD gene
  58. Knowledge explosion for monogenic skin diseases
  59. Identification of Two Novel Mutations in the SLC45A2 Gene in a Hungarian Pedigree Affected by Unusual OCA Type 4
  60. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes
  61. Difficulties of genetic counselling in rare, mainly neurogenetic disorders
  62. Identification of a novel missense GLRA1 gene mutation in hyperekplexia: a case report
  63. Ulcus vulvae acutum Lipschütz in two young female patients
  64. CTSC and Papillon-Lefevre syndrome
  65. Nemaline Myopathy Type 2 (NEM2)
  66. A newly identified missense mutation of the EDA1 gene in a Hungarian patient with Christ–Siemens–Touraine syndrome
  67. A novel seven-base deletion of the CTSC gene identified in a Hungarian family with Papillon-Lefèvre syndrome
  68. A Mutational Hotspot in CYLD Causing Cylindromas: A Comparison of Phenotypes Arising in Different Genetic Backgrounds
  69. Early detection of Angelman syndrome resulting from de novo paternal isodisomic 15q UPD and review of comparable cases
  70. A novel missense mutation of the CYLD gene identified in a Hungarian family with Brooke–Spiegler syndrome
  71. A newly identified missense mutation of the HR gene is associated with a novel, unusual phenotype of Marie Unna Hereditary Hypotrichosis 1 including limb deformities
  72. Mechanisms of IFN-γ–induced apoptosis of human skin keratinocytes in patients with atopic dermatitis
  73. MiR‐21 is up‐regulated in psoriasis and suppresses T cell apoptosis
  74. Germline Mutation in ATR in Autosomal- Dominant Oropharyngeal Cancer Syndrome
  75. Successful Treatment of Multiple Basaliomas with Bleomycin-based Electrochemotherapy: A Case Series of Three Patients with Gorlin-Goltz Syndrome
  76. HB-EGF induces COL7A1 expression
  77. MiR-125b, a MicroRNA Downregulated in Psoriasis, Modulates Keratinocyte Proliferation by Targeting FGFR2
  78. Intra-familial Variability of Ectodermal Defects Associated with WNT10A Mutations
  79. Strontium Ranelate-induced DRESS Syndrome with Persistent Autoimmune Hepatitis
  80. Revertant Mosaicism
  81. Schöpf-Schulz-Passarge syndrome resulting from a homozygous nonsense mutation in WNT10A
  82. Identification of a homozygous deletion mutation in C16orf57 in a family with Clericuzio‐type poikiloderma with neutropenia
  83. New perspective in immunotherapy: local imiquimod treatment
  84. New insights into hereditary angio-oedema: Molecular diagnosis and therapy
  85. The molecular skin pathology of familial primary localized cutaneous amyloidosis
  86. The anti‐apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non‐coding RNA, PRINS
  87. Blistering skin diseases: a bridge between dermatopathology and molecular biology
  88. Common IL-31 Gene Haplotype Associated with Non-atopic Eczema is Not Implicated in Epidermolysis Bullosa Pruriginosa
  89. Recurrent European missense mutation in the F12 gene in a British family with type III hereditary angioedema
  90. The altered expression of syndecan 4 in the uninvolved skin of venous leg ulcer patients may predispose to venous leg ulcer
  91. The Arg160Trp Allele of Melanocortin‐1 Receptor Gene Might Protect Against Vitiligo†
  92. Tumor Necrosis Factor-α −308 Polymorphism and Leg Ulceration – Possible Association with Obesity
  93. The expression of keratinocyte growth factor receptor (FGFR2‐IIIb) correlates with the high proliferative rate of HaCaT keratinocytes
  94. Single Nucleotide Polymorphisms of the Fibroblast Growth Factor Receptor 2 Gene in Patients with Chronic Venous Insufficiency with Leg Ulcer
  95. Optimal Adrenergic Support in Septic Shock Due to Peritonitis
  96. EFFECTS OF PENTASTARCH RESUSCITATION IN SEPTIC SHOCK